In univariate survival analysis, positive NGAL expression and strong NGAL staining intensity in breast carcinoma cells were highly significantly associated with decreased DFS in the entire cohort (NGAL expression: HR = 1.82, p<0.001; NGAL intensity: HR = 2.16, p<0.001). This evidence concerns the gene LCN2 and breast carcinoma.